UA88127C2 - Tablet for prevention and treatment of dental and periodontium diseases - Google Patents

Tablet for prevention and treatment of dental and periodontium diseases

Info

Publication number
UA88127C2
UA88127C2 UAA200906497A UAA200906497A UA88127C2 UA 88127 C2 UA88127 C2 UA 88127C2 UA A200906497 A UAA200906497 A UA A200906497A UA A200906497 A UAA200906497 A UA A200906497A UA 88127 C2 UA88127 C2 UA 88127C2
Authority
UA
Ukraine
Prior art keywords
tablet
dental
prevention
treatment
magnesium
Prior art date
Application number
UAA200906497A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Тамази Омарович Манашеров
Светлана Константиновна Матело
Татьяна Владимировна Купец
Юрий Андреевич Федоров
Original Assignee
Общество С Ограниченной Ответственностью "Вдс"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество С Ограниченной Ответственностью "Вдс" filed Critical Общество С Ограниченной Ответственностью "Вдс"
Publication of UA88127C2 publication Critical patent/UA88127C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to stomatology and specifically to a tablet for prevention and treatment of dental and periodontium diseases. The tablet contains the following components at the ratio, wt %: Magnesium sulfate or magnesium chloride or magnesium lactate or magnesium oxalate: 3.26-5.26, Pyridoxine hydrochloride: 0.060-0.074, Thiamin mononitrate: 0.50-0.062, Calcium glycerophosphate: 30.0-38.9, Ground laminaria thallus or dried laminaria aqueous extract: 1.1-2.2, Stevioside: 0.3-0.9, Sorbite: 10.0-25.0, Xylite: 10.0-25.0, Auxiliary components: 15.62-45.42.
UAA200906497A 2007-08-29 2008-07-01 Tablet for prevention and treatment of dental and periodontium diseases UA88127C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA200701932A EA011286B1 (en) 2007-08-29 2007-08-29 Tablet for prophylaxis and treatment of teeth diseases and parodentium

Publications (1)

Publication Number Publication Date
UA88127C2 true UA88127C2 (en) 2009-09-10

Family

ID=40429096

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200906497A UA88127C2 (en) 2007-08-29 2008-07-01 Tablet for prevention and treatment of dental and periodontium diseases

Country Status (3)

Country Link
EA (1) EA011286B1 (en)
UA (1) UA88127C2 (en)
WO (1) WO2009031922A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA013370B1 (en) * 2009-05-15 2010-04-30 Общество С Ограниченной Ответственностью "Вдс" Formulation for prophylaxis of dental diseases
RU2708624C1 (en) * 2019-04-16 2019-12-10 Федеральное государственное автономное образовательное учреждение высшего образования "Северо-Восточный федеральный университет имени М.К.Аммосова" Method of treating periodontitis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1657188A1 (en) * 1989-07-17 1991-06-23 Ленинградский Государственный Институт Усовершенствования Врачей Им.С.М.Кирова Tooth-paste
SU1644963A1 (en) * 1989-08-22 1991-04-30 Ленинградский Государственный Институт Усовершенствования Врачей Им.С.М.Кирова Tooth paste
CN1101673C (en) * 1997-08-21 2003-02-19 哈木拉提·吾甫尔 Oral-cavity cleaning liquor for preventing and curing disease of oral cavity and preparation method thereof
WO2001054657A1 (en) * 2000-01-27 2001-08-02 The Procter & Gamble Company Improved low-cost dentifrice composition
RU2248787C2 (en) * 2000-10-25 2005-03-27 Дзе Проктер Энд Гэмбл Компани Compositions for dental care
SE0003907D0 (en) * 2000-10-27 2000-10-27 Swe Dencare Composition for the elimination of tartar from the mouth
RU2293551C1 (en) * 2005-05-23 2007-02-20 Ооо "Вдс" Composition for mouth cavity disease prophylaxis

Also Published As

Publication number Publication date
EA200701932A1 (en) 2009-02-27
WO2009031922A1 (en) 2009-03-12
EA011286B1 (en) 2009-02-27

Similar Documents

Publication Publication Date Title
IS8485A (en) Use of substituted 2-aminotetralins in the prevention of Parkinson's disease
MY148108A (en) Medicaments for the treatment or prevention of fibrotic diseases
UA97489C2 (en) Pharmaceutical composition containing amorphous rosuvastatin calcium
UA94580C2 (en) 39-desmethoxyrapamycin analogue with increased blood-brain barrier permeability for the treatment of a medical condition resulting from neural injury or disease
EA200800880A1 (en) COMBINATION OF ROSIGLITAZONE AND DROPSEEN, INTENDED TO IMPROVE COGNITIVE FUNCTION
ZA200806778B (en) N-Hydroxyacrylamide compounds
MY174002A (en) Combination theraphy for the treatment of diabetes
EA201200968A1 (en) USE OF TRANS-CLOMIPHENE FOR THE PREVENTION OR TREATMENT OF DIABETES TYPE 2 IN MEN
TW200637544A (en) Medicaments for the treatment or prevention of fibrotic diseases
MA32785B1 (en) METHOD OF TREATING OR PREVENTING THROMBOSIS USING DIGIGATRAN ETEXILATE OR SALT THEREOF WITH INCREASED EFFICACY THAN CLASSICAL WARFARIN THERAPY
ATE457729T1 (en) USE OF ALLOPURINOL FOR THE TREATMENT OF PALMAR/PLANTAR ERYTHRODYSAESTHESIA
TW200635595A (en) Medicaments for the treatment of prevention of fibrotic diseases
MY139498A (en) Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines
TW200742580A (en) Methods for treating nephrolithiasis
ATE516035T1 (en) FIXED DOSE ASSOCIATION OF PHYTATE AND ZINC
MX2021009755A (en) Combinations of beta-lactam compounds and probenecid and uses thereof.
UA88127C2 (en) Tablet for prevention and treatment of dental and periodontium diseases
CY1108588T1 (en) ULTRASONAL INTERFECTION (WATER) AND HUMAN SOLUTION SOLUTION (hSEP) INHIBITORS FOR PREVENTION AND TREATMENT OF NEUROLOGY
JO2820B1 (en) Combination of a Bisthiazolium Salt or a Precursor Thereof and Artemisinin or a Derivative Thereof for the Treatment of Severe Malaria
AR030660A1 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF AN ILLNESS ASSOCIATED WITH AN EXCESS OF IL-12 PRODUCTION
ATE339206T1 (en) USE OF LORNOXICAM OR LORNOXICAM ANALOG COMPOUNDS
HRP20090102T3 (en) Improved pharmaceutical composition containing ace inhibitor and method for the preparation thereof
AR062613A1 (en) FORMULATION OF ORGANIC COMPOUNDS
IN2014DN06198A (en)
CY1110563T1 (en) Derivative of isoxazolic acid for the relief of neuropathic pain